drugset / Trial / NCT00034814
Multicenter Trial for Adults With Partial Seizures
Treatment
Summary
To compare seizure frequency in patients with refactory partial seizures (with or without generalization) who are taking Talampanel versus placebo as an add-on therapy to other licensed concomitant antiepileptic drugs (AEDs) and to determine the safety of Talampanel in this group of patients.
Timeline
- Start
- 2002-01
- Primary completion
- 2006-01
- Completion
- 2006-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Talampanel | Small molecule | 25 mg | — |
| Subject | Talampanel | Small molecule | 35 mg | — |
| Subject | Talampanel | Small molecule | 50 mg | — |